Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1290930 | 0.82 | KMT2A (0.58) | ALDH1A1TSHRCA1CA2CA12 | |
| SCHEMBL7132233 | 0.82 | HDAC1 (0.47) | ALDH1A1CA1CA2KMT2AHDAC1 | |
| Ethylene Glycol SCHEMBL9217560 | 0.81 | ALDH1A1 (0.50) | ALDH1A1TSHRCA1CA2HPGD | |
| SCHEMBL68148 | 0.81 | ALDH1A1 (0.59) | ALDH1A1TSHRCA1CA2CA12 | |
| SCHEMBL20587670 | 0.81 | ALDH1A1 (0.59) | ALDH1A1TSHRCA1CA2CA12 | |
| SCHEMBL186794 | 0.80 | CA1 (0.64) | ALDH1A1CA1CA2KMT2ASMN1; SMN2 | |
| SCHEMBL27335185 | 0.79 | ALDH1A1 (0.41) | ALDH1A1CA1CA2KMT2ASMN1; SMN2 | |
| Alcohol SCHEMBL29110704 | 0.79 | ALDH1A1 (0.48) | ALDH1A1TSHRCA1CA2CA12 | |
| SCHEMBL8186531 | 0.79 | PRSS1 (0.52) | PRSS1PRSS2PRSS3ALDH1A1EPHX2 | |
| Methylene Chloride SCHEMBL29223376 | 0.78 | ALDH1A1 (0.52) | ALDH1A1TSHRCA1CA2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111393748-A | Silicon dioxide modified polypropylene antibacterial material and preparation method thereof | 卢静 | 2020-07-10 | — | — | CN | claimed |
| WO-2023280177-A1 | SMALL MOLECULE COMPOUND TARGETING BCL9/β-CATENIN INTERACTION | 南通聚太生物科技有限公司 | 2023-01-12 | — | — | WO | disclosed |
| CN-111393748-A | Silicon dioxide modified polypropylene antibacterial material and preparation method thereof | 卢静 | 2020-07-10 | — | — | CN | disclosed |
| US-9776141-B2 | Composite polyamide membrane post-treated with nitrous acid | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-03 | — | — | US | disclosed |
| US-9700524-B2 | Pharmaceutical compositions comprising monoterpenes | NEONC TECHNOLOGIES INC. (US) | 2017-07-11 | — | — | US | disclosed |
| US-20170182467-A1 | COMPOSITE POLYAMIDE MEMBRANE POST-TREATED WITH NITROUS ACID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-06-29 | — | — | US | disclosed |
| US-20170088494-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | NATIONAL INSTITUTES OF HEALTH | 2017-03-30 | — | — | US | disclosed |
| US-9529257-B2 | Hard mask composition and method for forming pattern using same | CHEIL INDUSTRIES, INC. (KR) | 2016-12-27 | — | — | US | disclosed |
| US-9498448-B2 | Pharmaceutical compositions comprising monoterpenes | NeOne Technologies, Inc. (US) | 2016-11-22 | — | — | US | disclosed |
| US-20160332942-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA | 2016-11-17 | — | — | US | disclosed |
| US-20110280860-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | NEONC TECHNOLOGIES INC. | 2011-11-17 | — | — | US | disclosed |
| US-20110105484-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | PAIN THERAPEUTICS | 2011-05-05 | — | — | US | disclosed |
| US-20110105547-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | PAIN THERAPEUTICS | 2011-05-05 | — | — | US | disclosed |
| US-20110042614-A1 | CHIRAL COMPOUNDS, LIQUID CRYSTAL COMPOSITIONS AND POLYMER NETWORKS DERIVED THEREFROM | E.I.DU PONT DE NEMOURS AND COMPANY (US) | 2011-02-24 | — | — | US | disclosed |
| US-20080176816-A1 | Method of making and using an adenosine analogue | ACADEMIA SINICA | 2008-07-24 | — | — | US | disclosed |
| US-7345079-B2 | Treatment of disorder related to low cyclic GMP levels | YUNG SHIN PHARMACEUTICALS INDUSTRIAL CO., LTD (TW) | 2008-03-18 | — | — | US | disclosed |
| EP-1499627-A2 | NUCLEASE RESISTANT CHIMERIC OLIGONUCLEOTIDES | ISIS Pharmaceuticals, Inc. (US) | 2005-01-26 | — | — | EP | disclosed |
| US-20030175906-A1 | Nuclease resistant chimeric oligonucleotides | ISIS PHARMACEUTICALS, INC. | 2003-09-18 | — | — | US | disclosed |
| US-20030158403-A1 | Nuclease resistant chimeric oligonucleotides | ISIS PHARMACEUTICALS, INC. | 2003-08-21 | — | — | US | disclosed |
| WO-2003004602-A2 | NUCLEASE RESISTANT CHIMERIC OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 2003-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160332942-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | PRSS1 2335/4885PRSS2 2858/4885PRSS3 3085/4885 |
| US-20080176816-A1 | Method of making and using an adenosine analogue | HTT, ADA, GDA | PRSS1 4125/4885PRSS2 3693/4885PRSS3 2840/4885 |
| US-20110105484-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | FLNA, FLNB, OPRK1 | PRSS1 3044/4885PRSS2 3586/4885PRSS3 3295/4885 |
| US-20110042614-A1 | CHIRAL COMPOUNDS, LIQUID CRYSTAL COMPOSITIONS AND POLYMER NETWORKS DERIVED THEREFROM | THEM6, WEE1, NOTUM | PRSS1 4745/4885PRSS2 4187/4885PRSS3 4193/4885 |
| US-20110105547-A1 | FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC | FLNA, FLNB, OPRK1 | PRSS1 3044/4885PRSS2 3586/4885PRSS3 3295/4885 |
| US-20110280860-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | PRSS1 2335/4885PRSS2 2858/4885PRSS3 3085/4885 |
| US-20030158403-A1 | Nuclease resistant chimeric oligonucleotides | RNASE1, DIS3, DCLRE1B | PRSS1 2733/4885PRSS2 2286/4885PRSS3 1286/4885 |
| US-20030175906-A1 | Nuclease resistant chimeric oligonucleotides | DIS3, RNASE1, DCLRE1B | PRSS1 2595/4885PRSS2 1965/4885PRSS3 1135/4885 |
| US-20170088494-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | PRSS1 2335/4885PRSS2 2858/4885PRSS3 3085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.